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Variable number of tandem repeat (VNTR) sequences in the
genome can have functional consequences that contribute to
human disease. This is the case for the CEL gene, which is
speciﬁcally expressed in pancreatic acinar cells and encodes the
digestive enzyme carboxyl ester lipase. Rare single-base deletions (DELs) within the ﬁrst (DEL1) or fourth (DEL4) VNTR
segment of CEL cause maturity-onset diabetes of the young,
type 8 (MODY8), an inherited disorder characterized by
exocrine pancreatic dysfunction and diabetes. Studies on the
DEL1 variant have suggested that MODY8 is initiated by CEL
protein misfolding and aggregation. However, it is unclear how
the position of single-base deletions within the CEL VNTR
affects pathogenic properties of the protein. Here, we investigated four naturally occurring CEL variants, arising from
single-base deletions in different VNTR segments (DEL1,
DEL4, DEL9, and DEL13). When the four variants were
expressed in human embryonic kidney 293 cells, only DEL1
and DEL4 led to signiﬁcantly reduced secretion, increased
intracellular aggregation, and increased endoplasmic reticulum
stress compared with normal CEL protein. The level of Oglycosylation was affected in all DEL variants. Moreover, all
variants had enzymatic activity comparable with that of normal
CEL. We conclude that the longest aberrant protein tails,
resulting from single-base deletions in the proximal VNTR
segments, have highest pathogenic potential, explaining why
DEL1 and DEL4 but not DEL9 and DEL13 have been observed
in patients with MODY8. These ﬁndings further support the
view that CEL mutations cause pancreatic disease through
protein misfolding and proteotoxicity, leading to endoplasmic
reticulum stress and activation of the unfolded protein
response.

Variable number of tandem repeat (VNTR) is a term used to
describe short DNA sequence motifs that are consecutively
* For correspondence: Anders Molven, anders.molven@uib.no.

repeated several times in the genome (1). As these motifs are
very polymorphic and inherited in a Mendelian pattern, they
have had a tremendous impact on our ability to identify individuals based on biological samples (2). The VNTRs are
most often located in noncoding regions of the genome, but
some are found in promoter regions (3) or within coding DNA
sequences (4). In such cases, a VNTR may inﬂuence the
expression levels or functional properties of the corresponding
protein. Moreover, as repeated DNA motifs are prone to undergo mutations by DNA slippage and unequal crossing-over,
VNTRs affecting the protein product are intriguing candidates
for human disease associations (1).
One such example is found in the CEL gene, encoding the
digestive enzyme carboxyl ester lipase, which is mainly
expressed in the acinar cells of the pancreas (5). CEL contains
11 exons, where the last exon has a VNTR that consists of
nearly identical 33–base pair segments, each encoding 11
amino acids (5). The number of repeated segments within the
VNTR may vary between three and 23. However, in all populations examined so far, the most common CEL allele contains 16 repeats, encoding a protein with a predicted molecular
mass of 79 kDa (6–11) (Fig. 1). As the CEL protein is both Nand O-glycosylated, the observed mass is considerably larger
(12, 13). In particular, threonine residues within the VNTRencoded tail region undergo O-glycosylation (13). This
modiﬁcation may serve to prevent rapid degradation of the
CEL protein but might also facilitate secretion or increase
solubility (14). Intriguingly, the pattern of O-glycosylation in
CEL reﬂects the ABO blood group of the individual (15).
A single-base deletion (DEL) in the ﬁrst repeat of the CEL
VNTR leads to maturity-onset diabetes of the young, type 8
(MODY8), a dominantly inherited syndrome of exocrine
pancreatic dysfunction and diabetes (16). The corresponding
pathogenic protein has been referred to as CEL-MODY or
CEL-MUT in previous publications (17, 18) but will hereafter
be denoted as CEL-DEL1 (abbreviated: DEL1) to emphasize
that the deletion is positioned in the ﬁrst repeat. Another
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Figure 1. Schematic overview of the different CEL protein variants encoded by constructs used in the present study. A, the normal CEL protein (CELWT) with 16 repeated segments, each consisting of 11 amino acids and encoded by the VNTR. This is the most common CEL variant in the general
population. The yellow box symbolizes the N-terminal signal peptide, whereas light blue boxes represent the normal repeats. The unique C-terminal
sequence of CEL-WT is symbolized by a gray box. Also indicated are residues required for bile salt binding, N- and O-glycosylation, phosphorylation, and
catalysis. B, overview of the different CEL protein variants investigated. Predicted molecular mass (kDa) and the isoelectric point (pI) of each variant are
shown on the right side. All DEL constructs were based on a 16-repeat backbone. Light blue boxes represent normal repeat sequences, whereas red boxes
indicate aberrant repeats resulting from the frameshifts introduced by single–base deletions in the CEL VNTR. CEL-TRUNC is an artiﬁcial variant lacking the
VNTR region and was included as control construct. Elements of A and B are not drawn to scale. DEL, deletion; VNTR, variable number of tandem repeat.

single-base deletion in the fourth repeat of the CEL VNTR was
found in a family with a similar phenotype as the original
MODY8 family (16), and this protein will be denoted as DEL4.
Owing to frameshifts and premature stop codons, DEL1 and
DEL4 are both truncated CEL variants with aberrant protein C
termini (Fig. 1). Very rare single-base deletions in the more
distal repeats of the CEL VNTR have been observed when
screening population-based materials (own unpublished data).
It is unknown whether such variants also associate with the
disease.
We have previously shown that DEL1 has a high propensity
to form both intracellular and extracellular aggregates (18).
We have also found that after secretion, there is cellular reuptake followed by lysosomal degradation of the DEL1 protein,
resulting in reduced viability of pancreatic cell lines (17, 19).
Furthermore, we have reported that DEL1 causes endoplasmic
reticulum (ER) stress, induction of the unfolded protein
response, and subsequent apoptosis (20). Taken together,
these results indicate that the CEL protein in MODY8 has
acquired a negative gain-of-function effect and that the disease
follows the protein misfolding–dependent pathway of
pancreatitis (21).
The aim of the present study was to examine the pathogenicity of single-base deletions naturally occurring in the CEL
VNTR. We tested how the position of a deletion within this
region affects the functional properties of the encoded CEL
protein variant. We therefore compared the DEL1 and DEL4
variants causing MODY8 with two deletions (DEL9 and
DEL13) that we have observed in the general population. Our
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data suggest a correlation between the position of a CEL
VNTR single-base deletion and its functional impact on the
protein, where increasingly distal mutations have less pathogenic potential.

Results
Cellular properties of CEL proteins are inﬂuenced by the V5/
His tag
In previous cellular studies of the pathogenic DEL1
variant, we have expressed the protein both with and without
a V5/His epitope tag fused to the C terminus (15–20).
Although epitope tags are very useful tools for protein puriﬁcation and detection, the charged and hydrophilic residues of such tags may sometimes have a signiﬁcant impact
on the biochemical properties of the protein (22, 23). Before
initiating the functional study of our set of CEL DEL variants, we therefore investigated how the V5/His tag might
inﬂuence the CEL protein.
Human embryonic kidney 293 (HEK293) cells were transiently transfected with plasmids expressing DEL1 with and
without tag, followed by either cellular fractionation and
Western blotting or immunocytochemistry. As controls, we
included a construct encoding the normal CEL protein with 16
repeats (WT) and a construct with a stop codon introduced at
the beginning of VNTR segment 1 (TRUNC, Fig. 1). The latter
construct encodes a truncated CEL protein that has no
repeated segments and is unlikely to undergo O-glycosylation.
It is an artiﬁcial variant not being reported in human materials.
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Figure 2. Secretion and intracellular distribution of tagged versus untagged CEL variants in HEK293 cells. HEK293 cells were transiently transfected
with plasmids encoding CEL-WT, CEL-DEL1, or CEL-TRUNC with or without the V5/His tag (+/−). The expressed CEL proteins were examined by Western
blotting (A) and immunocytochemistry (B). Representative images from n = 3 independent experiments are shown. A, secretion was evaluated as CEL levels
detected in the conditioned medium. Intracellular distribution was assessed by analyzing the soluble (lysate) and insoluble (pellet) cellular fractions. Cells
transfected with the empty vector (EV) were used as the negative control, whereas GAPDH expression was monitored for control of loading. The red arrow
points at a very weak band for untagged CEL-WT protein in the pellet fraction. The stippled line indicates an unrelated lane removed from the images. B,
transfected cells were subjected to immunostaining and confocal microscopy. CEL protein is stained green and cell nuclei are stained blue. Scale bars
represent 50 μm. DEL, deletion; HEK293, human embryonic kidney 293.

We found the WT and DEL1 proteins expressed without the
V5/His tag to be less secreted than the tagged variants
(Fig. 2A). In addition, the untagged variants showed slightly
stronger bands in the detergent-insoluble pellet fraction,
indicating that they are more prone to aggregate. Consistent
with these ﬁndings, confocal imaging demonstrated a stronger
intracellular signal for the untagged WT and DEL1 proteins
than for their tagged counterparts (Fig. 2B). The TRUNC
protein did not display clear differences with or without the tag
in our experiments.
Based on these results, we concluded that the V5/His tag
may increase the solubility of CEL protein variants, possibly
via interactions involving the VNTR-encoded region. In previous studies with tagged variants (17–19), we may therefore
have underestimated the detrimental cellular effects of DEL1.
Consequently, we decided to use only untagged protein variants in the present study.
VNTR composition affects CEL protein secretion and
intracellular distribution
We have previously shown that the disease-causing DEL1
variant exhibits intracellular retention and reduced secretion
(20). In the ﬁrst article describing MODY8, we also identiﬁed a
family with a DEL4 mutation of CEL (16), but this variant has
not been studied functionally. When screening 1287 subjects
of the general Norwegian population, we observed three subjects having a DEL9 mutation, that is, a single–base deletion in

segment number 9 of the CEL VNTR. This corresponded to a
carrier frequency of 0.0023. Similarly, we identiﬁed one subject
with a single–base deletion in VNTR segment 13 (DEL13,
carrier frequency 0.0008).
We therefore decided to test how the position of the deletion within the VNTR might affect pathogenicity by investigating the identiﬁed set of CEL variants with mutations in
different repeat segments (Table 1; Fig. 1). Constructs
encoding the CEL-WT and CEL-TRUNC proteins were
included as reference variants in all experiments. Initially, we
studied the effect of the four protein variants on secretion and
intracellular distribution. HEK293 cells were transiently
transfected with the six constructs, and the conditioned medium, soluble lysate, and insoluble pellet were analyzed by
Western blotting.
When compared with CEL-WT, secretion and intracellular distribution varied substantially between the variants
Table 1
Analyzed single-base deletions in the VNTR region of the CEL gene
Variant designation

Nucleotide changea

Amino acid change

DEL1
DEL4
DEL9
DEL13

c.1686delT
c.1785delC
c.1950delC
c.2082delC

p.Val563Cysfs*132
p. Val596Cysfs*99
p.Val651Cysfs*44
p.Val695*

DEL, deletion; VNTR, variable number of tandem repeat.
a
Position according to NCBI reference mRNA sequence NM_001807.4 (www.ncbi.
nlm.nih.gov/nuccore/NM_001807.4).
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Figure 3. Secretion and cellular distribution of different CEL protein variants. A, HEK293 cells were transiently transfected with plasmids encoding the
CEL variants shown in Figure 1 and subjected to cellular fractionation and Western blotting. Cells transfected with the empty vector (EV) were used as
negative control, whereas GAPDH expression was monitored for control of loading. Secretion was assessed as CEL levels detected in the conditioned
medium. Intracellular distribution was evaluated by analyzing the soluble (lysate) and insoluble (pellet) fractions after lysis of the cells. The stippled line
indicates an unrelated lane removed from the images. Representative images from n = 3 independent experiments are shown. B, quantiﬁcation of Western
blot band intensities in the three experiments, adjusted to the GAPDH levels and normalized to the CEL-WT lane. Error bars are SD. Statistical signiﬁcance is
indicated as follows for band intensities different from that of CEL-WT: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. HEK293, human embryonic kidney 293.

(Fig. 3). We found signiﬁcantly reduced secretion for
DEL1 (38-fold), DEL4 (7.5-fold), and TRUNC (23-fold). In
contrast, variants DEL9 and DEL13 displayed a secretion
level similar to that of the WT protein. In the pellet
fraction, there was a 2.8-fold increase for DEL1, 2.1-fold
increase for DEL4, and 6.4-fold increase for TRUNC.
Band intensities of DEL9 and DEL13 appeared slightly
stronger than for the WT protein, but differences were
not statistically signiﬁcant. Moreover, signiﬁcantly lower
levels of all DEL variants (DEL1: 7.4-fold, DEL4: 7.1-fold,
DEL9: 4.2-fold, DEL13: 2.1-fold) were detected in the
soluble lysate fraction (Fig. 3). TRUNC exhibited a 2.5fold reduction that did not reach statistical signiﬁcance
because of large experimental variation. The general
decrease in abundance of all variants in the lysate fraction
when compared with the CEL-WT level is likely to reﬂect
their increased abundance in the pellet fraction. The
intracellular levels of the variants should be considered as
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a total of the lysate and pellet fraction and appear as such
to be relatively constant.
The extent of O-glycosylation varies between CEL DEL variants
Interestingly, the four DEL variants migrated with clearly
different band sizes in the SDS-PAGE gels despite having
very similar predicted molecular masses (compare Figs. 1
and 3). This suggested that the variants differ at the level
of post-translational modiﬁcation. Because CEL is heavily
O-glycosylated (13, 15, 24), a likely explanation for the
observed size differences could be variations in O-glycosylation. Prediction of theoretical O-glycosylation sites in
the VNTR region revealed that CEL-WT has the highest
number of potential sites (n = 36), whereas DEL1, DEL4,
DEL9, and DEL13 contain 13, 18, 23, and 26 sites, respectively (Fig. S1). Thus, the proximal DEL variants DEL1 and
DEL4 have fewer predicted O-glycosylation sites than the
distal variants DEL9 and DEL13. This observation might at
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least to some degree explain the migration differences
observed in Figure 3.
To experimentally investigate the effect of O-glycosylation
on the various DEL variants, an isogenic cell model with
(HEK293 SimpleCells) and without (regular HEK293 cells)
KO of the gene encoding the Cosmc chaperone was used
(25, 26). As a result of this KO, the enzymatic activity that
provides O-glycan elongation beyond the initial GalNAc-α1
residue on O-linked glycoproteins (T-synthase) is absent. We
transfected SimpleCells and their nonaltered HEK293
counterparts with the different CEL variants and analyzed
the protein mass by Western blotting (Fig. 4). We found that
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Figure 4. Expression of CEL variants in an O-glycosylation-deﬁcient cellular model. HEK293 cells (A) and HEK293 cells with Cosmc KO (SimpleCells) (B)
were transiently transfected with plasmids encoding the CEL variants shown in Figure 1 and analyzed by Western blotting. Cells transfected with the empty
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J. Biol. Chem. (2021) 296 100661

5

Position and proteotoxicity of CEL deletion mutations
in SimpleCells (i.e., attachment of GalNAc-α1 onto Ser/Thr
residues), which probably explains why size differences still
are present after expressing the DEL variants in this cellular
model. Taken together, our results indicate that full
O-glycosylation is important for efﬁcient expression and
secretion of CEL and that the level of O-glycosylation varies
considerably between the DEL variants.
Expression of DEL1 and DEL4 in HEK293 cells increases ER
stress
Expression of the DEL1 variant induces ER stress in both
HEK293 cells and in the pancreatic acinar cell line AR42J

(20). In the present study, we wanted to conﬁrm this ﬁnding
and to compare the ability of the different DEL variants to
cause ER stress, both at the mRNA and the protein levels. In
addition to analyzing an ER stress master regulator (the
chaperone GRP78), all three branches of the unfolded protein response were investigated, namely the PERK, IRE1a,
and ATF6 pathways (27). HEK293 cells were transiently
transfected with our set of CEL variants, followed by
expression analysis of six marker genes (Fig. 5). Cells
expressing DEL1 had a 1.3-fold increase in mRNA levels for
XBP1s, belonging to the IRE1a arm. For DEL1, we also
observed increased levels of borderline signiﬁcance for
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GRP78 and ATF3 (1.5-fold and 1.3-fold, respectively). In
addition, cells expressing the DEL4 variant showed a 1.5-fold
higher level for GRP78, a 1.2-fold higher expression of the
ER folding chaperone HYOU1 belonging to the ATF6 arm,
and 1.8-fold higher expression of the proapoptotic factor
CHOP belonging to the PERK arm (Fig. 5). DEL9 and DEL13
did not result in signiﬁcantly elevated levels of any of the
tested marker genes.
At the protein level, we examined the effect of CEL variants
on the ER chaperones GRP78 and calnexin, and the ER stress
transducer PERK. Clear differences between the CEL variants

were observed in the insoluble pellet fraction but not in the
soluble lysate (Fig. 6A). Compared with WT, DEL1 induced
signiﬁcantly higher levels of GRP78 (4.2-fold), calnexin (36fold), and PERK (8.1-fold) (Fig. 6B). For DEL4, we observed
a 2- to 10-fold increase in expression of the same ER stress
markers although the differences did not quite reach statistical signiﬁcance because of large experimental variation
(Fig. 6B).
When the data of Figs. 5 and 6 were considered together, the
position of the deletion within the VNTR showed an impact on
ER stress signaling: A stress response was induced by both

Figure 6. Effect of CEL variants on ER stress markers at the protein level. A, HEK293 cells were transiently transfected with plasmids encoding the CEL
variants shown in Figure 1, and expression of ER stress markers was assessed by Western blotting of the soluble (lysate) and insoluble (pellet) fractions. Cells
transfected with the empty vector (EV) were used as negative control, whereas GAPDH expression was monitored for control of loading. For each of the ER
stress markers GRP78, calnexin, and PERK, representative images from n = 3 independent experiments are shown. Stippled lines for two of the markers
indicate unrelated lanes removed from the images. B, quantiﬁcation of marker band intensities after adjustment to the GAPDH levels and normalization to
the expression in CEL-WT–transfected cells. Error bars are SD. The asterisk denotes statistical signiﬁcance (p ≤ 0.05) for band intensities different from that of
the CEL-WT experiment. ER, endoplasmic reticulum; HEK293, human embryonic kidney 293.

J. Biol. Chem. (2021) 296 100661

7

Position and proteotoxicity of CEL deletion mutations
DEL1 and DEL4, and this effect leveled off as the deletions
were positioned more distally.
DEL variants display lipolytic activity comparable with that of
normal CEL
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To test whether the single-base deletions could impair the
protein’s primary function, CEL enzymatic activity was
measured. Conditioned medium from HEK293T cells
expressing the CEL variants was collected, and the different
variants were puriﬁed to near homogeneity as demonstrated by
SDS-PAGE (Fig. 7A). Lipolytic activity in the medium was then
measured with trioctanoate as the substrate (Fig. 7B). To
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Figure 7. Enzymatic activity of the studied CEL variants. HEK293T cells
were transiently transfected with plasmids encoding the CEL variants
shown in Figure 1. A, SDS-PAGE of CEL variants puriﬁed from the conditioned medium and stained with Gel-Code Blue. The same amount of
protein was loaded in each lane. The stippled line indicates an unrelated
lane removed from the image. A representative image from n = 3 independent experiments is shown. B, CEL lipolytic activity in the medium
measured with trioctanoate as the substrate. The activity was adjusted for
band density (as in panel A) and molecular weight of each variant. Error bars
are SD. HEK293, human embryonic kidney 293.

8 J. Biol. Chem. (2021) 296 100661

altered levels of secretion, activities were ﬁrst normalized
against the molecular weight of the variant and then plotted
after adjusting for the relative band intensities visualized in
Figure 7A. All variants exhibited enzymatic activities comparable with that of the normal CEL protein (Fig. 7B). The
relative activities ranged from 76% (DEL1) to 91% (DEL13).
The TRUNC variant had an enzyme activity almost identical to
that of CEL-WT (95%), suggesting that a complete loss of the
VNTR region does not affect the lipolytic activity.

Discussion
The inherent variation and instability of VNTR sequences
imply that these regions are excellent candidates for associations with human disease. We have previously investigated
whether the number of VNTR segments in the CEL gene inﬂuences the risk for exocrine pancreatic disease, however,
without ﬁnding any evidence that this is the case (9–11). In the
current report, we have therefore focused on single–base deletions within the VNTR. These variants are extremely rare
and are present in MODY8 families (16) or may occasionally
be revealed when screening large cohorts of human DNA
samples. As some cellular properties of the DEL1 variant are
clearly altered from those of the normal CEL protein (16–20),
we here investigated the impact of varying deletion positions
within the VNTR.
Owing to the frameshift effect, each of the four DEL variants
analyzed in this study has a C-terminal amino acid sequence
that differs substantially from that of normal CEL. Moreover,
between the DEL proteins, there is also considerable variation
in the extension of normal versus aberrant sequence repeats
(Fig. 1B). Discrepancies in cellular properties of the tested
variants are therefore likely to reﬂect biochemical effects
arising from their dissimilar amino acid compositions.
Notably, the frameshifts alter the pI of the protein variants.
The consequence is that the overall acidic charge of the
normal CEL protein transforms to the basic side for DEL1,
DEL4, and DEL9 (Fig. 1B). The positively charged VNTR region observed for DEL1 and DEL4, and to some degree for
DEL9, could contribute to aggregation and pathogenicity
through change of short- and long-range interactions between
CEL protein monomers and between CEL and membrane
surfaces (18). It is therefore worth noting that high-molecularweight protein bands were present only for the DEL1 and
DEL4 variants (weak bands in the pellet fraction shown in
Fig. 3A).
Moreover, the frameshift caused by the deletion mutations
introduces several cysteine residues in the aberrant tails of
DEL1, DEL4, and DEL9 (12, nine, and four cysteines, respectively; Fig. S2). In contrast, the tails of DEL13 and CEL-WT
have no cysteines. In addition to charge effects, the pronounced tendency to aggregate observed for DEL1 and DEL4
might therefore be attributed to formation of intramolecular
and intermolecular disulﬁde bridges between opposing
cysteine residues, as discussed previously (20) and also reported in other pathological proteins (28, 29). The aggregation
effect may be important for understanding the pathogenicity of
the DEL variants, and it could be of interest to analyze effects
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of the DEL-speciﬁc sequences also outside the context of the
CEL protein, for example, by fusing the aberrant protein tails
to various reporter proteins.
The DEL13 variant may be protected against aggregation
because it keeps an overall acidic charge and has no cysteine
residues in its VNTR region. Regarding the observed highmolecular-weight forms of CEL, we speculate that they also
could be protein complexes with binding partners such as the
GRP94 chaperone (30) or ubiquitinated proteins targeted for
proteasomal degradation.
The normal CEL VNTR region is heavily O-glycosylated, a
post-translational modiﬁcation considered important for
proper secretion and stability of the protein (13, 24). For
several of the DEL variants, two or more bands were detected
in the insoluble and soluble cell fractions (Fig. 3A), likely to
represent fully glycosylated and partially glycosylated CEL, as
observed previously (18). Although Western blotting is not an
accurate way of estimating the molecular mass of a protein,
none of the tested variants migrated with a band size that
corresponded to their unmodiﬁed amino acid composition.
Notably, DEL1 and DEL4, both variants with dramatically
fewer O-glycosylation sites, were found to be less well secreted
(Fig. 3A).
The rationale behind expressing the DEL variants in
HEK293 SimpleCells, a cellular model with deﬁcient
O-glycosylation, was to obtain variants with an even and
truncated glycosylation proﬁle. Ser and Thr residues in the
VNTR region would then contain at most one GalNAc residue
(with or without a terminal sialyl group). This might enable us
to evaluate whether there was a substantial difference in the
basic glycosylation pattern among the variants. When
expressed in SimpleCells, the CEL proteins displayed a dramatic shift in the band size. All variants migrated with a band
size closer to that predicted from their amino acid composition
(Fig. 4B), except for TRUNC, which has no VNTR sequence
and only one theoretical site for O-glycosylation (Fig. S1). Of
note, TRUNC was the most abundant variant in the pellet
fraction (Fig. 3). Also, when expressed in bacteria, truncated
(and nonglycosylated) CEL was found as large aggregates
recovered in inclusion bodies (31), further proving the
importance of this post-translational modiﬁcation on CEL
secretion. The fact that the band sizes of the DEL variants still
varied when expressed in SimpleCells despite very similar
predicted molecular masses (Fig. 4B) could indicate a large
difference in glycan site occupancy. This might be due to the
inability of the GalNAc transferases (and sialidases) to reach or
recognize certain areas in the aberrant tail, or a consequence of
extensive intramolecular or intermolecular disulﬁde bonds.
The morphological changes of the pancreatic parenchyma
observed in MODY8 are consistent with a phenotype of
chronic pancreatitis (16, 32). The classic model for understanding the pathogenesis of pancreatitis involves inappropriate intracellular activation of trypsinogen or failure of
intracellular trypsin inactivation (33). However, it is becoming
increasingly clear that there are also trypsin-independent disease mechanisms, caused by digestive enzyme misfolding and
ER stress (21, 34–36). We therefore investigated the effect of

DEL variant expression on well-known ER stress markers at
the RNA and protein level (Figs. 5 and 6). There was a clear
trend for DEL1 and DEL4 to upregulate ER stress markers,
both when compared with WT and with the distal DEL variants DEL9 and DEL13. Increased signaling was detected in the
three canonical branches of the unfolded protein response that
are under the control of PERK, IRE1a, and ATF6. This is
consistent with ER stress caused by DEL1 and DEL4 protein
aggregation, intramolecular and intermolecular disulﬁde
bridge formation, reduced O-glycosylation and/or impaired
transit through the secretory pathway.
As the variants DEL1 and DEL4 led to mRNA upregulation
of the proapoptotic marker CHOP, we speculate that increased
cell death may be implicated in the disease mechanism. This is
supported by a previous study, showing that DEL1 induced
apoptosis in rat pancreatic acinar cells (20). At the protein
level, we found signiﬁcant differences only in the insoluble
pellet fraction and not in the soluble lysate (Fig. 6B). For the
folding chaperone GRP78, this could be explained by the
protein binding tightly to misfolded CEL variants, thereby
being pulled down in the pellet fraction as a protein complex.
All DEL variants displayed lipolytic activity comparable with
that of the normal CEL protein (Fig. 7). There was a slight,
gradual decrease in relative activity from DEL13 (91%) to
DEL1 (76%), suggesting that the aberrant protein repeats
might have a minor effect on CEL enzymatic function. The
TRUNC variant displayed almost normal lipolytic activity
(95%), a result in line with previous studies showing that
complete truncation of the VNTR region does not compromise the enzymatic ability of CEL (37, 38).
Under any circumstances, we ﬁnd it unlikely that reduced
lipolytic activities can explain pathogenicity of the DEL variants. First, the observed differences do not appear large enough
to alter physiological function of CEL, although the possibility
remains that activity against other substrates than trioctanoate
could be more severely affected. Second, a mouse model with a
full-body KO of CEL did not recapitulate any aspect of the
MODY8 pancreatic phenotype (39). Third, the cytotoxic effects
observed for different variants of the pathogenic CEL-HYB1
protein (40) could not be attributed to differences in the lipolytic activity (41). Finally, the presence of a normal gene in the
heterozygous state is expected to compensate for any loss of
activity from a rare CEL mutation. Taken together, all available
data favor the hypothesis that pathogenic CEL variants initiate
pancreatic disease through a dominant-negative gain-of-function effect, rather than via a loss-of-function mechanism.
A limitation of our study is that pancreatic acinar cells were
not used as model system. Still, our data demonstrate that the
position of single-base deletions in the CEL VNTR has great
impact on protein cytotoxicity. When analyzed in transfected
HEK293 cells, the pathogenic DEL1 and DEL4 variants found
in MODY8 families had the strongest effect on protein
secretion, protein aggregation, and ER stress. On the other
hand, DEL13 behaved more like normal CEL and must be
considered a benign variant. We evaluate DEL9 to have intermediate effects, but given that this variant so far has not
been reported in any MODY family, we conclude that it is
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likely benign in this disease context. The CEL VNTR is a region very prone to mutational events (5). Should single-base
deletions in the second or third VNTR repeat (i.e., DEL2 and
DEL3) be identiﬁed, we predict that they will be pathogenic.
For any DEL5–DEL8 variant that might be observed, genetic
segregation analysis and functional evaluation will be necessary to determine their pathogenic potential.

Experimental procedures
Plasmid constructions
Previously, we made the plasmid pcDNA3/CEL-WT 14R
(with 14 VNTR segments) for expression of the normal CEL
protein in mammalian cells (20). For this study, a PshAI/XhoI
cDNA fragment encoding normal CEL with 16 VNTR segments was synthesized by GenScript and used to replace the
corresponding fragment in pcDNA3/CEL-WT 14R. All four
CEL DEL constructs were then made through mutagenesis
service provided by GenScript using the newly created
pcDNA3/CEL-WT with 16 repeated segments as template.
The CEL-TRUNC construct was generated by QuikChange II
XL site-directed mutagenesis kit (Agilent Technologies) using
pcDNA3/CEL-WT 14R as template (20).
For experiments comparing expression of epitope-tagged
versus untagged CEL variants, the tagged plasmids have been
described before (19). In short, the constructs were all based
on a pcDNA3.1 vector containing a V5/His-tag (Invitrogen).
Untagged constructs for comparison were prepared by introducing a stop codon into the pcDNA3.1/V5-His constructs
using the same site-directed mutagenesis kit as above. The
plasmid contains an XhoI restriction site directly before the
epitope tag sequence, in which the stop codon was created.
Antibodies and reagents
Two anti-CEL antibodies were used: a rabbit polyclonal
antibody for immunoblotting (against the truncated CEL
variant pV562Δ, as described (20)), and a mouse mAb for
immunocytochemistry (As20.1, against the CEL globular
domain), kindly provided by Prof. Olle Hernell (Department of
Clinical Sciences, Umeå University, Umeå, Sweden). Additional primary antibodies were rabbit polyclonal anti-GRP78
antibody (cat. 21685, Abcam), rabbit monoclonal anticalnexin (C5C9, cat. 2679) and mouse monoclonal antiPERK (D11A8, cat. 5683) from Cell Signaling Technology,
and mouse monoclonal anti-GAPDH (sc-47724, Santa Cruz
Biotechnology,). Secondary antibodies were HRP-goat antirabbit (cat. 656120, Invitrogen), HRP-donkey anti-mouse
(sc-2318, Santa Cruz Biotechnology), and Alexa Fluor 488
anti-mouse (cat. A11017, Invitrogen).
RNeasy Mini Kit was from Qiagen. Polyethyleneimine (PEI)
was from Polysciences. High-Capacity cDNA Reverse Transcription Kit was from Applied Biosystems. Amersham
Hybond P Western Blotting polyvinylidene diﬂuoride membranes were from GE Healthcare. TGX Precast protein gel
(4–15%) and Blotting-Grade Blocker were from Bio-Rad. PolyL-lysine, fetal bovine serum (FBS), PBS, PenicillinStreptomycin, and cOmplete Mini Protease inhibitor cocktail
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tablets were from Sigma-Aldrich. ProLong Gold Antifade Solution containing 40 ,6-diamidino-2-phenylindole nuclear stain,
Antibiotic Antimycotic, and Lipofectamine 2000 were from
Invitrogen. Radioimmunoprecipitation assay buffer lysis buffer
(10×), Triton X-100, and Tween-20 were from Merck Millipore. NuPAGE Sample Reducing Agent (10×), NuPAGE
lithium dodecyl sulphate (LDS) Sample Buffer (4×), Dulbecco’s
modiﬁed Eagle’s medium (DMEM) with high glucose
(4500 mg/L), NuPAGE Bis-Tris Protein gels (10% or 4–12%,
1.0 mm, ten-well), Pierce BCA Protein Assay, Pierce ECL Plus
Western Blotting Substrate, Opti-MEM I Reduced Serum
Medium, and GelCode Blue Stain Reagent were obtained from
Thermo Fisher Scientiﬁc.
Cell culture of HEK293 and HEK293T cells
HEK293 cells (Clontech Laboratories) were used for most
experiments described in this study. For the enzymatic activity
assay, HEK293T cells from American Type Culture Collection
were used. HEK293 Cosmc-KO cells (referred to as SimpleCells
throughout the text) and their unaltered counterpart were obtained from the laboratory of Prof. Henrik Clausen (Copenhagen
Center for Glycomics, Denmark). All cell lines were maintained
in a growth medium with high glucose (4500 mg/L) supplemented with 10% FBS and either 100 U/ml of Antibiotic Antimycotic or 10 mg/ml of Penicillin-Streptomycin in humidiﬁed
atmosphere with 5% CO2 at 37  C.
Transient transfections
For transfection of HEK293 cells, Lipofectamine 2000 was
used according to the manufacturer’s instructions. Cells were
transfected with plasmids encoding CEL-WT, single-base DEL
variants (DEL1, DEL4, DEL9, or DEL13), or CEL-TRUNC,
either with or without the V5/His tag. The empty vector
(either pcDNA3 or pcDNA3.1-V5/His) was included as a
negative control. Samples were harvested for analysis 48 h after
transfection for all experiments.
For the enzymatic activity assay, HEK293T cells were used.
Cells were grown in 10-cm culture dishes in a regular medium
until reaching 70 to 90% conﬂuence. Next, the cells were
transfected with plasmids expressing different CEL variants
using PEI, which had been dissolved in ddH2O at a concentration of 1 μg/μl (pH 7.4) and sterilized using a 0.22-μm ﬁlter.
Before transfection, cells were switched to 10 ml DMEM
without FBS. For one dish, 15 μg plasmid DNA was mixed with
45 μl PEI solution in 500 μl Opti-MEM I Reduced Serum
Medium. The mixture was added to the culture medium of
HEK293T cells after 30-min incubation at room temperature
(RT). The cells were grown for 16 to 20 h before the medium
was switched to 10 ml Opti-MEM I Reduced Serum Medium
containing antibiotics. The cells were grown for another 24 h,
the conditioned medium was harvested, and the cells were
refreshed with another 10 ml of Opti-MEM I Reduced Serum
Medium. The conditioned medium was again collected after
24-h incubation. The harvested media were pooled and ﬁltered
with 0.45-μm Steritop bottle top ﬁlters (Millipore) to remove
debris before protein puriﬁcation.
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Cell fractionation and collection of conditioned media
The conditioned medium was collected and analyzed as the
medium fraction. The cells were lysed in ice-cold radioimmunoprecipitation assay buffer supplemented with the
protease inhibitor. After 30-min incubation on ice, the lysate
was centrifuged at 14,000g for 15 min at 4  C. The supernatant
was isolated and analyzed as the soluble lysate fraction. The
pellet was washed twice in PBS, boiled at 95  C in 2× LDS
sample buffer and reducing agent, and analyzed as the insoluble pellet fraction. All fractions were analyzed by Western
blotting.
Western blotting
For detection of CEL protein, 4 μg of the soluble lysate
fraction was used. For the medium and insoluble pellet fractions, the volume loaded on the SDS gel was the same as for
the corresponding lysate. LDS sample buffer and reducing
agent were added to all samples. Before loading, the medium
and soluble lysate fractions were denatured on a heating block
at 56  C for 15 min, whereas the pellet fractions were denatured at 95  C for 15 min. The samples were loaded and
separated by 10% SDS-PAGE at 90 V for 15 min and then at
180 V for 1 h. Proteins were transferred to a polyvinylidene
diﬂuoride membrane by semiwet blotting using XCell Blot
Module chambers (Invitrogen) according to manufacturer’s
instructions. The proteins were detected using standard
methods, with primary antibody incubation overnight at 4  C
and secondary antibody incubation for 1 h at RT. Blots were
developed using Pierce ECL Plus Western Blotting Substrate,
and signals were analyzed using a Las 1000 Pro v2.6 software
imager (Fujiﬁlm). Band quantiﬁcation was performed using the
Multi Gauge v3.0 software (Fujiﬁlm). For ER stress markers,
20 μg (GRP78 and calnexin) or 40 μg (PERK) of the insoluble
pellet fraction was loaded and separated by 4 to 12% SDSPAGE. For ER stress analyses of the soluble lysate fractions,
10 μg protein was loaded on the gel. For analyses of CEL
expression in transfected SimpleCells, 10 μg protein was
loaded on the gel and separated by 10% SDS-PAGE.
Immunocytochemistry and confocal microscopy
HEK293 cells were seeded onto coverslips (18 mm) coated
with poly-L-lysine, transfected as described above and ﬁxed in
3% paraformaldehyde for 30 min. Immunostaining was performed as described previously (17). Results were evaluated
with an SP5 AOBS confocal microscope (Leica Microsystems)
with 63×/1.4 NA NAHCX Plan-Apochromat oil immersion
objective, 1.2 airy unit pinhole aperture, and appropriate
ﬁlter combinations. Images were acquired with 405 diode and
argon ion/argon krypton lasers (Leica) and processed using
LAS AF Lite (Leica), Photoshop CC, and Adobe Illustrator CC
(Adobe Systems).
RNA extraction and real-time quantitative PCR
The medium was removed, and the cells were washed before
total RNA was extracted using the RNeasy Mini Kit according
to the manufacturer’s protocol. For cDNA synthesis, the High-

Capacity cDNA Reverse Transcription Kit was used with total
RNA input of 20 ng for each cDNA synthesis reaction. The
real-time PCR was performed with SyBR Green on a RotorGene Q cycler (Qiagen). Gene expression was calculated as
copies/μl using the standard curve approach. The standards
were made with suitable primers in a conventional PCR.
GAPDH, OAZ1, and ACTB were used as reference genes.
Protein puriﬁcation and enzymatic activity assay
CEL protein variants were puriﬁed by HiTrap Heparin HP
Afﬁnity Column (GE Healthcare Life Sciences) controlled by
an ÄKTA pure protein puriﬁcation system as described previously (20). Protein concentration was determined by
measuring absorbance at 280 nm using the corresponding
extinction coefﬁcient for each CEL variant. Five micrograms of
each puriﬁed protein was resolved by 4 to 15% TGX Precast
protein gel and stained with GelCode Blue stain reagent to
assess molecular mass, homogeneity, and integrity. Functional
characterization of recombinant CEL protein variants was
carried out by measuring lipase activity against trioctanoate in
the presence of 12 mM sodium cholate using a pH-stat
(Radiometer Analytical) at pH 8.0. For each assay, 5 μg of
puriﬁed CEL protein was used. The lipolytic activities were
expressed in international lipase units/mg of the enzyme (1
unit corresponds to 1 μmol of fatty acid released/min). The
activities were adjusted according to densitometry and to the
molecular weight of each variant.
Statistical analysis
The two-tailed Student’s t test was used for all statistical
analyses. Statistical calculations were carried out using
Microsoft Excel 2016. p-values ≤ 0.05 were considered as
statistically signiﬁcant. Results are given as the mean ± SD.
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All data that support the ﬁndings of this study are included
within the article.
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